Table 1.
Patient characteristics
| n (%) | Median (range) | |
| Gender | ||
| Female | 459 (62) | |
| Male | 277 (38) | |
| Age (years) | 60 (18–87) | |
| Number of previous lines of treatment | 2 (0–17) | |
| Chemotherapy | 1 (0–10) | |
| Targeted therapy | 0 (0–4) | |
| Hormonotherapy | 0 (0–6) | |
| Immunotherapy | 0 (0–3) | |
| Drug combinations | 0 (0–9) | |
| Tumour location | ||
| Breast | 130 (18) | |
| Lung | 92 (13) | |
| Ovary | 76 (10) | |
| Head and neck | 73 (10) | |
| Colorectal | 67 (9) | |
| Cervix | 41 (6) | |
| Prostate | 37 (5) | |
| Uterus | 32 (4) | |
| Pancreas | 30 (4) | |
| Brain | 22 (3) | |
| Bone | 17 (2) | |
| Soft tissue | 16 (2) | |
| Eye | 15 (2) | |
| Liver | 11 (2) | |
| Salivary gland | 11 (2) | |
| Urothelial | 11 (2) | |
| Stomach | 7 (1) | |
| Vulva | 7 (1) | |
| Skin | 6 (1) | |
| Appendix | 4 (1) | |
| Gall bladder | 3 (0.4) | |
| Pleura | 3 (0.4) | |
| Lacrimal gland | 2 (0.3) | |
| Oesophagus | 2 (0.3) | |
| Adrenal gland | 2 (0.3) | |
| Thymus | 2 (0.3) | |
| Blood | 1 (0.1) | |
| Kidney | 1 (0.1) | |
| Unknown | 14 (2) | |
| Total | 736 (100) | |